INTRODUCTION AND OVERVIEW
The 11 th World Kidney Day will be celebrated on March 10, 2016 and will focus on kidney disease in childhood and the antecedents of adult kidney disease, which can begin even in the perinatal period. This annual event, sponsored jointly by the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF), has become a highly successful effort to inform the general public and policymakers about the importance and ramifications of kidney disease.
Children who endure acute kidney injury (AKI) from a wide variety of conditions may have long-term sequelae that can lead to chronic kidney disease (CKD) many years later (Furth et al. 2006; Warady & Chadha 2007; Goldstein 2012; Harambat et al. 2012) . Further, CKD in childhood, much of it congenital, and complications from the many non-renal diseases that can affect the kidneys secondarily, not only lead to substantial morbidity and mortality during childhood but also result in medical issues beyond childhood ( Figure 1 ). Indeed, childhood deaths from a long list of communicable diseases are inextricably linked to kidney involvement. In addition, a substantial body of data indicates that hypertension, proteinuria and CKD in adulthood have childhood antecedents-from as early as in utero and perinatal life (see Table 1 ).
The prevalence of CKD in childhood is rare-and has been variously reported at 15-74.7 per million children (Warady & Chadha 2007 (Saran et al. 2015) and the EDTA registry (ESPN/ERA-EDTA Registry 2016) include data on paediatric ESRD, and some on CKD. Projects such as the ItalKid (Ardissino et al. 2003) and Chronic Kidney Disease in Children (CKiD) (Wong et al. 2012 ) studies, as well as registries that now exist in many countries provide important information, and more is required.
SPECTRUM OF PAEDIATRIC KIDNEY DISEASES
The conditions that account for CKD in childhood, with a predominance of congenital and hereditary disorders, differ substantially from those in adults. To date, mutations in more than 150 genes have been found to alter kidney development or specific glomerular or tubular functions (Eckardt et al. 2013 ). Most of these genetic disorders present during childhood, and many lead to progressive CKD. Congenital anomalies of the kidney and urinary tract (CAKUT) account for the largest category of CKD in children (Table 2 ) and include renal hypoplasia/dysplasia and obstructive uropathy. Many paediatric glomerulopathies are caused by genetic or acquired defects of the podocytes, the unique cell type lining the glomerular capillaries.
CONGENITAL KIDNEY DISEASE AND DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, RENAL ENDOWMENT AND IMPLICATIONS
In regions where antenatal fetal ultrasounds are routine, many children with urologic abnormalities are identified antenatally, which permits early intervention. However, in much of the world, children with structural abnormalities are not identified until much later, when symptoms develop. Both diagnosis and therapy of kidney disease in childhood have matured over the past several decades. While generalized screening for proteinuria, hematuria and urinary tract infections are carried out in some countries and regions, there is a lack of consensus as to its effectiveness. However, there is general agreement that children with antenatal ultrasound studies indicating possible genitourinary anomalies, children with a family history of kidney disease, and children with signs such as failure to thrive or a history of urinary tract infection, voiding dysfunction or an abnormal appearing urine should be examined. Initial screening would include a focused physical examination and a urine dipstick, formal urinalysis and a basic chemistry panel, followed by a more focused evaluation if indicated.
Depending on the diagnosis, definitive therapy may be indicated. However, the evidence that therapy will slow progression of CKD in childhood remains limited. Angiotensin converting enzyme inhibitors, angiotensin receptor blockers, antioxidants and, possibly, dietary changes may be indicated, depending on the diagnosis. However, dietary changes need to permit adequate growth and development. The ESCAPE trial provided evidence that strict blood pressure control retards progression of CKD in children irrespective of the type of underlying kidney disease (Group et al. 2009 ).
Some very young children may require renal replacement therapy, even in early infancy. Recent data pooled from registries world wide indicate good survival, even when dialysis is required from neonatal age (Harambat et al. 2012; van Stralen et al. 2014) . Kidney transplantation, the preferred renal replacement therapy in children, is suitable from the second year of life, with excellent patient and allograft survival, growth and development.
In addition to those children with congenital kidney disease, perinatal events may affect future health in the absence of evident kidney disease in early life (Hoy et al. 2010) . Premature infants appear to be particularly at risk for kidney disease long after they are born, based both on observational cohort studies, as well as on case reports. Even very premature infants now survive, including many born well before nephrogenesis is complete (Flynn et al. 2014 ). The limited data available indicate that in the process of neonatal ICU care, such babies receive many nephrotoxins, and that those dying prior to discharge from the nursery have fewer and larger glomeruli (Rodriguez et al. 2004 ). Additionally, those surviving have evidence of renal impairment that may be subtle (Abitbol et al. 2003) . Even more concerning, abundant epidemiologic data indicate that persons born at term but with relatively low birth weights may be at high risk for hypertension, albuminuria and CKD in later life (Hodgin et al. 2009 ). When direct measurements are pursued, such persons, as adults, may have fewer nephrons, thus a low cardiorenal endowment.
In focusing on children for World Kidney Day, we would note that it is key to follow kidney function and blood pressure throughout life in those persons born early or small-fordates. By doing so, and avoiding nephrotoxic medications throughout life, it should be possible to avert CKD in many people.
RESOURCES AND THERAPEUTICS FOR CHILDREN-DIFFERENCES FROM THERAPEUTICS IN ADULTS
Disparities exist in the availability of resources to treat AKI in children and young people; consequently, too many children and young adults in developing nations succumb if AKI occurs. To address the problem the ISN has initiated the Saving Young Lives Project, which aims both to prevent AKI with prompt treatment of infection and/or delivery of appropriate fluid and electrolyte therapy, and to treat AKI when it occurs. This ongoing project in SubSaharan Africa and South East Asia, in which four kidney foundations participate equally (IPNA, ISN, ISPD and SKCF) 1 , focuses on establishing and maintaining centers for the care of AKI, including the provision of acute peritoneal dialysis. It links with the ISN's 0 by 25 project, which calls on members to ensure by 2025 that nobody dies from preventable and acute kidney injury.
TRANSITION FROM PAEDIATRIC TO ADULT CARE
Transition of care for adolescents with kidney disease into an adult setting is critical both for patients and their caregivers. Non-adherence is a too-frequent hallmark of transition from paediatric to adult care for young patients with chronic disease states (Watson 2000; Jarzembowski et al., 2004; Aujoulat et al. 2011 ). Hence, considered steps combined with systematically defined procedures supported by validated pathways and credible guidelines must be in place to ensure successful outcomes.
CALL FOR GENERATING FURTHER INFORMATION AND ACTION
Given vulnerabilities of children with kidney disease including impact on growth and development and future life as an adult, and given the much greater proportion of children in developing nations facing resource constraints educating everyone involved is imperative in order to realign communications and actions (White et al. 2010; Gallieni et al. 2014 ). These efforts should foster regional and international collaborations and exchange of ideas between local kidney foundations, professional societies, other not-for-profit organisations, and states and governments, so as to help empower all stakeholders to improve the health, well-being and quality of life of children with kidney diseases and to ensure their longevity into adulthood.
